ReviewAdvanced healthcare materials2026
Extracellular Vesicles in Wearable Delivery Systems for Cosmeceutical Applications.
Review in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gram-Positive and Gram-Negative Probiotic Extracellular Vesicles: Mechanisms of Immune Modulation and Therapeutic Opportunities in Atopic Dermatitis.Clinical reviews in allergy & immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Extracellular vesicles (EVs) have attracted increasing interest in cosmeceuticals due to their regenerative, anti-inflammatory, and skin-repairing properties. However, conventional topical and injectable EV delivery approaches are often limited by poor skin penetration, instability, and inconsistent bioavailability. This review summarizes recent advances in wearable-assisted EV delivery systems for cosmetic and dermatological applications, with particular emphasis on transdermal delivery strategies, sustained release, and personalized skin monitoring. Wearable platforms, including microneedle patches, hydrogels, iontophoretic devices, and stimuli-responsive systems, may improve EV retention, transdermal transport, and localized delivery compared with conventional topical formulations. Different EV sources and wearable formats are discussed together with their advantages, formulation considerations, and translational limitations. Despite these opportunities, challenges related to EV stability, scalable production, regulatory classification, and long-term safety remain important barriers to clinical and commercial translation. Continued advances in biomaterials, wearable electronics, and formulation strategies may further support the development of EV-enabled personalized skincare systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.